D Mavalankar
Overview
Explore the profile of D Mavalankar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah K, Varna V, Sharma U, Mavalankar D
QJM
. 2023 Mar;
116(7):611-612.
PMID: 36971583
No abstract available.
2.
Shah K, Punnapuzha V, Sharma U, Mavalankar D
QJM
. 2022 Jul;
116(5):408-409.
PMID: 35861424
No abstract available.
3.
Shah K, Varna V, Sharma U, Mavalankar D
QJM
. 2022 Feb;
115(10):665-672.
PMID: 35166850
Background: The evidence regarding the efficacy of vitamin D supplementation in reducing severity of COVID-19 is still insufficient. This is partially due to the lack of primary robust trial-based data...
4.
Shah K, Upadhyaya M, Kandre Y, Pandya A, Saraf V, Saxena D, et al.
QJM
. 2021 Jul;
114(7):476-495.
PMID: 34293142
Background: Given the limited and diverse nature of published literature related to COVID-19 in pediatrics, it is imperative to provide evidence-based summary of disease characteristics for guiding policy decisions. We...
5.
Shah K, Saxena D, Mavalankar D
QJM
. 2021 Jan;
114(3):175-181.
PMID: 33486522
Objective: Current meta-analysis aims to understand the effect of oral supplementation of vitamin D on intensive care unit (ICU) requirement and mortality in hospitalized COVID-19 patients. Methods: Databases PubMed, preprint...
6.
Shah K, Saxena D, Mavalankar D
QJM
. 2020 Jul;
113(12):841-850.
PMID: 32726452
Coronavirus disease 2019 (COVID-19) is a novel virus with continuously evolving transmission trends. Contact tracing and quarantining of positive cases are chief strategies of disease control that has been accepted...
7.
Iyer V, Sidney K, Mehta R, Mavalankar D
BMJ Glob Health
. 2017 Jun;
1(1):e000019.
PMID: 28588914
Objective: The state of Gujarat in India (population 60 million) has implemented a public-private partnership (PPP) with private obstetricians called the Chiranjeevi Yojana (CY) since 2006. This study investigated the...
8.
Manimunda S, Mavalankar D, Bandyopadhyay T, Sugunan A
Epidemiol Infect
. 2010 Nov;
139(9):1410-2.
PMID: 21073766
Port Blair, the capital city of the Union Territory of Andaman and Nicobar Islands in the republic of India, witnessed an outbreak of chikungunya (CHIK) fever in 2006. Although no...
9.
Mavalankar D, Raman P, Dwivedi H, Jain M
Int J Gynaecol Obstet
. 2004 Oct;
87(1):88-97.
PMID: 15464790
In resource-poor countries, substantial sums of money from governments and international donors are used to purchase equipment for health facilities. WHO estimates that 50-80% of such equipment remains non-functional. This...
10.